YZYBIO-B (02496) announced that the company has obtained approval from the Hong Kong Stock Exchange on February 4, 2026, for the listing and trading of 68.0103 million H-shares. This amount is equivalent to the total number of the company's non-listed shares to be converted and listed.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.